Selecting here opens the current stored cards. The pinned link below records their fingerprints. Do not enter patient information in links or searches.
Share or print this source review
1 local source card selected. Local card fingerprints checked where supplied. This is not an original-document hash, source-currency guarantee or clinical approval. Record-level cautions below are the current library's cautions, not a frozen prior version.
Copy is optional; the link can be selected and copied manually. No patient data or dose decision is collected.
Clinical context remains essential
Independent clinical review is pending. Confirm indication, exact formulation/route, population, renal measure and units, kidney-function stability, dialysis prescription, interacting drugs, monitoring and source revision. An RX mirror and its original label are not independent corroboration. Missing disagreement notes do not certify agreement.
Check source scope before reading a dose
Mycamine - UCSF Infectious Diseases Management Program
Product / population
UCSF adult IV micafungin for candidemia/invasive candidiasis.
Renal method
Adult HD and nondialysis tables, indication-specific.
Source revision
Online guidance checked 2026-11-07; section revision not established.
UCSF Infectious Diseases Management Program · UCSF adult IV micafungin for candidemia/invasive candidiasis.
Renal method: Adult HD and nondialysis tables, indication-specific. Source date: Online guidance checked 2026-11-07; section revision not established. Retrieved: 2026-11-07
Professional guidance with defined scope. Publication date, institutional setting and source limitations remain controlling. This is not automatic preference over another source.
For candidemia or invasive candidiasis, UCSF lists 100 mg IV every 24 hours both off dialysis and in its HD tables. Other infections and prophylaxis use different doses. For deep infection, elevated MIC or obesity, consult the antimicrobial stewardship service.
RDM73-mycamine-professional-1 · Source locator: Adult nondialysis and dialysis, candidemia
This reference does not select a regimen. Complete the indication, measured/estimated renal function and trend, dialysis setting, source rationale, monitoring and reassessment plan in your institution's approved documentation system. Confirm the complete current source before adopting its regimen.
GlobalRPh Renal Dosing Master v7.4. Review the retrieval and revision dates attached to each source. Selecting a reference does not imply clinical verification.
